Ask AI
ProCE Banner Activity

Refractory Chronic Cough: Recognizing the Burden and Improving Care

Clinical Thought

Refractory chronic cough (RCC) is a prevalent condition, but its life-disrupting consequences go unrecognized, and RCC-related burdens experienced by patients are often compounded by delayed diagnosis and treatment. Fortunately, increased understanding of RCC, including its underlying neurogenic pathophysiology, can improve care for patients with this condition. Read this commentary for key patient perspectives and expert insights on RCC challenges, diagnosis, and management. 

Released: September 15, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

This educational activity is supported by an independent medical education grant from GSK.

GSK

Target Audience

This activity is intended for pulmonologists, allergists, otolaryngologists, nurse practitioners, and physician associates involved in the evaluation and management of patients with RCC.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Integrate awareness of RCC, including prevalence, patient characteristics, disease burden, and healthcare disparities, into clinical practice to improve recognition and optimize patient outcomes

Financial Disclosures

Primary Author

Peter Dicpinigaitis, MD: consultant/advisor/speaker: GSK, Hyfe, Nocion, Sensory Cloud, Seyltx, Trevi.

Additional Disclosures

Generative artificial intelligence (AI) tools were used for revising or refining educational content. All AI-assisted content underwent human review, editing, and validation by qualified faculty and accredited education staff to ensure scientific accuracy, balance, and compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education.